SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001750019-19-000053
Filing Date
2019-08-28
Accepted
2019-08-28 07:41:29
Documents
5
Effectiveness Date
2019-08-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A proxynotice.htm DEFA14A 25655
2 tcr2therapeuticsincnap27001.jpg GRAPHIC 83088
3 tcr2therapeuticsincnap27002.jpg GRAPHIC 128511
4 tcr2therapeuticsincnap27003.jpg GRAPHIC 39887
5 tcr2therapeuticsincnap27004.jpg GRAPHIC 27100
  Complete submission text file 0001750019-19-000053.txt   410627
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38811 | Film No.: 191059132
SIC: 2836 Biological Products, (No Diagnostic Substances)